Bischoff SC, Bernal W, Dasarathy S, Merli M, D. Plank L, Schütz T, Plauth M, Burgos Peláez R, Rivera Irigoin R. Guía Práctica ESPEN: nutrición clínica en las enfermedades del hígado. Nutr Hosp 2022;39(2): 434-472
Resumen
Introducción: la Guía Práctica se basa en la actual guía científica de la ESPEN sobre nutrición clínica en las enfermedades hepáticas.
CLINICAL PRACTICE GUIDELINES|
MAY 01, 2022
https://doi.org/10.1016/j.eprac.2022.03.010
Recommendation Summary: This guideline includes 34 evidence-based clinical practice recommendations for the diagnosis and management of persons with NAFLD and/or NASH and contains 385 citations that inform the evidence base.
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 12, December 2021, Pages e4861–e4871
Endocrinol Diabetes Metab Case Rep. 2021; 2021: 20-0140.
Published online 2021 Oct 14. doi: 10.1530/EDM-20-0140
November 18, 2021
N Engl J Med 2021; 385:1974-1980
DOI: 10.1056/NEJMoa2109409
The Journal of Clinical Endocrinology & Metabolism
https://doi.org/10.1210/clinem/dgab700
Published: 23 September 2021
Data regarding vitamin D status in patients affected by gastroenteropancreatic (GEP) neuroendocrine tumor (NET) are limited and often showing contrasting results. The aim of the study was to evaluate the incidence of vitamin D deficiency (<20 ng/mL) in GEP-NET patients and compare the 25-hydroxyvitamin D (25(OH)D) levels with clinicopathological parameters and clinical outcome.
